APO Research
Talk to an analyst

APO RESEARCH · REPORT

Dihydroartemisinin Tablets

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Dihydroartemisinin Tablets Market Outlook and Growth Opportunities 2026

27 December 2025190 pages

Choose your research edition.

Industry ResearchDihydroartemisinin Tablets Industry Research Report 2026115 pages · $2,950 USDIndustry Growth & TrendsGlobal Dihydroartemisinin Tablets Industry Growth and Trends Forecast to 203293 pages · $3,450 USDMarket StructureGlobal Dihydroartemisinin Tablets Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032181 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Dihydroartemisinin Tablets Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Dihydroartemisinin Tablets Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Dihydroartemisinin Tablets market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Dihydroartemisinin Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Dihydroartemisinin Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Dihydroartemisinin Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Dihydroartemisinin Tablets market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Dihydroartemisinin Tablets market include KPC Pharmaceuticals, Guilin Nantang Pharmaceutical, Schwitz Biotech, Ipca Laboratories, Centurion Healthcare and AdvaCare Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Dihydroartemisinin Tablets market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Dihydroartemisinin Tablets and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Dihydroartemisinin Tablets sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Dihydroartemisinin Tablets market size, projected growth trends, production technologies, key applications, and end-use industries.

Dihydroartemisinin Tablets Segment by Company

KPC Pharmaceuticals

Guilin Nantang Pharmaceutical

Schwitz Biotech

Ipca Laboratories

Centurion Healthcare

AdvaCare Pharma

Dihydroartemisinin Tablets Segment by Type

Compound Dihydroartemisinin

Single Dihydroartemisinin

Dihydroartemisinin Tablets Segment by Application

Hospital Pharmacy

Retail Pharmacy

Dihydroartemisinin Tablets Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Dihydroartemisinin Tablets status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Dihydroartemisinin Tablets market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Dihydroartemisinin Tablets significant trends, drivers, influence factors in global and regions.

6. To analyze Dihydroartemisinin Tablets competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Dihydroartemisinin Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Dihydroartemisinin Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Dihydroartemisinin Tablets.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Dihydroartemisinin Tablets market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Dihydroartemisinin Tablets industry.

Chapter 3: Detailed analysis of Dihydroartemisinin Tablets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Dihydroartemisinin Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Dihydroartemisinin Tablets in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Dihydroartemisinin Tablets Industry Trends Table 2. Dihydroartemisinin Tablets Industry Drivers Table 3. Dihydroartemisinin Tablets Industry Opportunities and Challenges Table 4. Dihydroartemisinin Tablets Industry Restraints Table 5. Global Dihydroartemisinin Tablets Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Dihydroartemisinin Tablets Revenue Share by Company (2021-2026) Table 7. Global Dihydroartemisinin Tablets Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Dihydroartemisinin Tablets Sales Volume Share by Company (2021-2026) Table 9. Global Dihydroartemisinin Tablets Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Dihydroartemisinin Tablets Company Ranking, (2024-2026) & (USD Million) Table 11. Global Dihydroartemisinin Tablets Key Company Manufacturing Base & Headquarters Table 12. Global Dihydroartemisinin Tablets Company, Product Type & Application Table 13. Global Dihydroartemisinin Tablets Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Dihydroartemisinin Tablets by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Compound Dihydroartemisinin Table 18. Significant Companies of Single Dihydroartemisinin Table 19. Global Dihydroartemisinin Tablets Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Dihydroartemisinin Tablets Sales Volume by Type (2021-2026) & (K Units) Table 21. Global Dihydroartemisinin Tablets Sales Volume by Type (2027-2032) & (K Units) Table 22. Global Dihydroartemisinin Tablets Sales Volume Share by Type (2021-2026) Table 23. Global Dihydroartemisinin Tablets Sales Volume Share by Type (2027-2032) Table 24. Global Dihydroartemisinin Tablets Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Dihydroartemisinin Tablets Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Dihydroartemisinin Tablets Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Dihydroartemisinin Tablets Sales Value Share by Type (2021-2026) Table 28. Global Dihydroartemisinin Tablets Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Hospital Pharmacy Table 30. Significant Companies of Retail Pharmacy Table 31. Global Dihydroartemisinin Tablets Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 32. Global Dihydroartemisinin Tablets Sales Volume by Application (2021-2026) & (K Units) Table 33. Global Dihydroartemisinin Tablets Sales Volume by Application (2027-2032) & (K Units) Table 34. Global Dihydroartemisinin Tablets Sales Volume Share by Application (2021-2026) Table 35. Global Dihydroartemisinin Tablets Sales Volume Share by Application (2027-2032) Table 36. Global Dihydroartemisinin Tablets Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Dihydroartemisinin Tablets Sales Value by Application (2021-2026) & (US$ Million) Table 38. Global Dihydroartemisinin Tablets Sales Value by Application (2027-2032) & (US$ Million) Table 39. Global Dihydroartemisinin Tablets Sales Value Share by Application (2021-2026) Table 40. Global Dihydroartemisinin Tablets Sales Value Share by Application (2027-2032) Table 41. Global Dihydroartemisinin Tablets Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 42. Global Dihydroartemisinin Tablets Sales by Region (2021-2026) & (K Units) Table 43. Global Dihydroartemisinin Tablets Sales Market Share by Region (2021-2026) Table 44. Global Dihydroartemisinin Tablets Sales by Region (2027-2032) & (K Units) Table 45. Global Dihydroartemisinin Tablets Sales Market Share by Region (2027-2032) Table 46. Global Dihydroartemisinin Tablets Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Dihydroartemisinin Tablets Sales Value by Region (2021-2026) & (US$ Million) Table 48. Global Dihydroartemisinin Tablets Sales Value Share by Region (2021-2026) Table 49. Global Dihydroartemisinin Tablets Sales Value by Region (2027-2032) & (US$ Million) Table 50. Global Dihydroartemisinin Tablets Sales Value Share by Region (2027-2032) Table 51. Global Dihydroartemisinin Tablets Market Average Price (US$/Unit) by Region (2021-2026) Table 52. Global Dihydroartemisinin Tablets Market Average Price (US$/Unit) by Region (2027-2032) Table 53. Global Dihydroartemisinin Tablets Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 54. Global Dihydroartemisinin Tablets Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 55. Global Dihydroartemisinin Tablets Sales by Country (2021-2026) & (K Units) Table 56. Global Dihydroartemisinin Tablets Sales Market Share by Country (2021-2026) Table 57. Global Dihydroartemisinin Tablets Sales by Country (2027-2032) & (K Units) Table 58. Global Dihydroartemisinin Tablets Sales Market Share by Country (2027-2032) Table 59. Global Dihydroartemisinin Tablets Sales Value by Country (2021-2026) & (US$ Million) Table 60. Global Dihydroartemisinin Tablets Sales Value Market Share by Country (2021-2026) Table 61. Global Dihydroartemisinin Tablets Sales Value by Country (2027-2032) & (US$ Million) Table 62. Global Dihydroartemisinin Tablets Sales Value Market Share by Country (2027-2032) Table 63. KPC Pharmaceuticals Company Information Table 64. KPC Pharmaceuticals Business Overview Table 65. KPC Pharmaceuticals Dihydroartemisinin Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. KPC Pharmaceuticals Dihydroartemisinin Tablets Product Portfolio Table 67. KPC Pharmaceuticals Recent Development Table 68. Guilin Nantang Pharmaceutical Company Information Table 69. Guilin Nantang Pharmaceutical Business Overview Table 70. Guilin Nantang Pharmaceutical Dihydroartemisinin Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. Guilin Nantang Pharmaceutical Dihydroartemisinin Tablets Product Portfolio Table 72. Guilin Nantang Pharmaceutical Recent Development Table 73. Schwitz Biotech Company Information Table 74. Schwitz Biotech Business Overview Table 75. Schwitz Biotech Dihydroartemisinin Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Schwitz Biotech Dihydroartemisinin Tablets Product Portfolio Table 77. Schwitz Biotech Recent Development Table 78. Ipca Laboratories Company Information Table 79. Ipca Laboratories Business Overview Table 80. Ipca Laboratories Dihydroartemisinin Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Ipca Laboratories Dihydroartemisinin Tablets Product Portfolio Table 82. Ipca Laboratories Recent Development Table 83. Centurion Healthcare Company Information Table 84. Centurion Healthcare Business Overview Table 85. Centurion Healthcare Dihydroartemisinin Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Centurion Healthcare Dihydroartemisinin Tablets Product Portfolio Table 87. Centurion Healthcare Recent Development Table 88. AdvaCare Pharma Company Information Table 89. AdvaCare Pharma Business Overview Table 90. AdvaCare Pharma Dihydroartemisinin Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. AdvaCare Pharma Dihydroartemisinin Tablets Product Portfolio Table 92. AdvaCare Pharma Recent Development Table 93. Key Raw Materials Table 94. Raw Materials Key Suppliers Table 95. Dihydroartemisinin Tablets Distributors List Table 96. Dihydroartemisinin Tablets Customers List Table 97. Research Programs/Design for This Report Table 98. Authors List of This Report Table 99. Secondary Sources Table 100. Primary Sources List of Figures Figure 1. Dihydroartemisinin Tablets Product Image Figure 2. Global Dihydroartemisinin Tablets Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Dihydroartemisinin Tablets Sales Value (2021-2032) & (US$ Million) Figure 4. Global Dihydroartemisinin Tablets Sales (2021-2032) & (K Units) Figure 5. Global Dihydroartemisinin Tablets Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Dihydroartemisinin Tablets Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Compound Dihydroartemisinin Image Figure 10. Single Dihydroartemisinin Image Figure 11. Global Dihydroartemisinin Tablets Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Dihydroartemisinin Tablets Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Dihydroartemisinin Tablets Sales Volume Share by Type (2021-2032) Figure 14. Global Dihydroartemisinin Tablets Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Dihydroartemisinin Tablets Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Dihydroartemisinin Tablets Sales Value Share by Type (2021-2032) Figure 17. Hospital Pharmacy Image Figure 18. Retail Pharmacy Image Figure 19. Global Dihydroartemisinin Tablets Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 20. Global Dihydroartemisinin Tablets Sales Volume Share 2021 VS 2025 VS 2032 Figure 21. Global Dihydroartemisinin Tablets Sales Volume Share by Application (2021-2032) Figure 22. Global Dihydroartemisinin Tablets Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Dihydroartemisinin Tablets Sales Value Share 2021 VS 2025 VS 2032 Figure 24. Global Dihydroartemisinin Tablets Sales Value Share by Application (2021-2032) Figure 25. Global Dihydroartemisinin Tablets Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 26. Global Dihydroartemisinin Tablets Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 27. Global Dihydroartemisinin Tablets Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 28. Global Dihydroartemisinin Tablets Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 29. North America Dihydroartemisinin Tablets Sales Value (2021-2032) & (US$ Million) Figure 30. North America Dihydroartemisinin Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 31. Europe Dihydroartemisinin Tablets Sales Value (2021-2032) & (US$ Million) Figure 32. Europe Dihydroartemisinin Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Asia-Pacific Dihydroartemisinin Tablets Sales Value (2021-2032) & (US$ Million) Figure 34. Asia-Pacific Dihydroartemisinin Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 35. South America Dihydroartemisinin Tablets Sales Value (2021-2032) & (US$ Million) Figure 36. South America Dihydroartemisinin Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Middle East & Africa Dihydroartemisinin Tablets Sales Value (2021-2032) & (US$ Million) Figure 38. Middle East & Africa Dihydroartemisinin Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 39. USA Dihydroartemisinin Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. USA Dihydroartemisinin Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. USA Dihydroartemisinin Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. Canada Dihydroartemisinin Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. Canada Dihydroartemisinin Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. Canada Dihydroartemisinin Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Mexico Dihydroartemisinin Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Mexico Dihydroartemisinin Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Mexico Dihydroartemisinin Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Germany Dihydroartemisinin Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Germany Dihydroartemisinin Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Germany Dihydroartemisinin Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. France Dihydroartemisinin Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. France Dihydroartemisinin Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. France Dihydroartemisinin Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. U.K. Dihydroartemisinin Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. U.K. Dihydroartemisinin Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. U.K. Dihydroartemisinin Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Italy Dihydroartemisinin Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Italy Dihydroartemisinin Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Italy Dihydroartemisinin Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Spain Dihydroartemisinin Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Spain Dihydroartemisinin Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Spain Dihydroartemisinin Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Russia Dihydroartemisinin Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Russia Dihydroartemisinin Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Russia Dihydroartemisinin Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Netherlands Dihydroartemisinin Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Netherlands Dihydroartemisinin Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Netherlands Dihydroartemisinin Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Nordic Countries Dihydroartemisinin Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Nordic Countries Dihydroartemisinin Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Nordic Countries Dihydroartemisinin Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. China Dihydroartemisinin Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. China Dihydroartemisinin Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. China Dihydroartemisinin Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Japan Dihydroartemisinin Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Japan Dihydroartemisinin Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Japan Dihydroartemisinin Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. South Korea Dihydroartemisinin Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. South Korea Dihydroartemisinin Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. South Korea Dihydroartemisinin Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. India Dihydroartemisinin Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. India Dihydroartemisinin Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. India Dihydroartemisinin Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Australia Dihydroartemisinin Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Australia Dihydroartemisinin Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Australia Dihydroartemisinin Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Southeast Asia Dihydroartemisinin Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Southeast Asia Dihydroartemisinin Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Southeast Asia Dihydroartemisinin Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Brazil Dihydroartemisinin Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Brazil Dihydroartemisinin Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Brazil Dihydroartemisinin Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Argentina Dihydroartemisinin Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Argentina Dihydroartemisinin Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Argentina Dihydroartemisinin Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Chile Dihydroartemisinin Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Chile Dihydroartemisinin Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Chile Dihydroartemisinin Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Colombia Dihydroartemisinin Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Colombia Dihydroartemisinin Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Colombia Dihydroartemisinin Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Peru Dihydroartemisinin Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Peru Dihydroartemisinin Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Peru Dihydroartemisinin Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Saudi Arabia Dihydroartemisinin Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Saudi Arabia Dihydroartemisinin Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Dihydroartemisinin Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Israel Dihydroartemisinin Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Israel Arabia Dihydroartemisinin Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Israel Arabia Dihydroartemisinin Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. UAE Dihydroartemisinin Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. UAE Dihydroartemisinin Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. UAE Dihydroartemisinin Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Turkey Dihydroartemisinin Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Turkey Dihydroartemisinin Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Turkey Dihydroartemisinin Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Iran Dihydroartemisinin Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Iran Dihydroartemisinin Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Iran Dihydroartemisinin Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Egypt Dihydroartemisinin Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Egypt Dihydroartemisinin Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Egypt Dihydroartemisinin Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Dihydroartemisinin Tablets Value Chain Figure 124. Manufacturing Cost Structure Figure 125. Dihydroartemisinin Tablets Sales Mode & Process Figure 126. Direct Comparison with Distribution Share Figure 127. Distributors Profiles Figure 128. Years Considered Figure 129. Research Process Figure 130. Key Executives Interviewed

Scope & coverage.

Types
  • Compound Dihydroartemisinin
  • Single Dihydroartemisinin
Applications
  • Hospital Pharmacy
  • Retail Pharmacy
Companies covered
  • KPC Pharmaceuticals
  • Guilin Nantang Pharmaceutical
  • Schwitz Biotech
  • Ipca Laboratories
  • Centurion Healthcare
  • AdvaCare Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Dihydroartemisinin Tablets Sales Value (2021-2032)
  4. 1.2.2 Global Dihydroartemisinin Tablets Sales Volume (2021-2032)
  5. 1.2.3 Global Dihydroartemisinin Tablets Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Dihydroartemisinin Tablets Market Dynamics
  1. 2.1 Dihydroartemisinin Tablets Industry Trends
  2. 2.2 Dihydroartemisinin Tablets Industry Drivers
  3. 2.3 Dihydroartemisinin Tablets Industry Opportunities and Challenges
  4. 2.4 Dihydroartemisinin Tablets Industry Restraints
3 Dihydroartemisinin Tablets Market by Company
  1. 3.1 Global Dihydroartemisinin Tablets Company Revenue Ranking in 2025
  2. 3.2 Global Dihydroartemisinin Tablets Revenue by Company (2021-2026)
  3. 3.3 Global Dihydroartemisinin Tablets Sales Volume by Company (2021-2026)
  4. 3.4 Global Dihydroartemisinin Tablets Average Price by Company (2021-2026)
  5. 3.5 Global Dihydroartemisinin Tablets Company Ranking (2024-2026)
  6. 3.6 Global Dihydroartemisinin Tablets Company Manufacturing Base and Headquarters
  7. 3.7 Global Dihydroartemisinin Tablets Company Product Type and Application
  8. 3.8 Global Dihydroartemisinin Tablets Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Dihydroartemisinin Tablets Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Dihydroartemisinin Tablets Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Dihydroartemisinin Tablets Market by Type
  1. 4.1 Dihydroartemisinin Tablets Type Introduction
  2. 4.1.1 Compound Dihydroartemisinin
  3. 4.1.2 Single Dihydroartemisinin
  4. 4.2 Global Dihydroartemisinin Tablets Sales Volume by Type
  5. 4.2.1 Global Dihydroartemisinin Tablets Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Dihydroartemisinin Tablets Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Dihydroartemisinin Tablets Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Dihydroartemisinin Tablets Sales Value by Type
  9. 4.3.1 Global Dihydroartemisinin Tablets Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Dihydroartemisinin Tablets Sales Value by Type (2021-2032)
  11. 4.3.3 Global Dihydroartemisinin Tablets Sales Value Share by Type (2021-2032)
5 Dihydroartemisinin Tablets Market by Application
  1. 5.1 Dihydroartemisinin Tablets Application Introduction
  2. 5.1.1 Hospital Pharmacy
  3. 5.1.2 Retail Pharmacy
  4. 5.2 Global Dihydroartemisinin Tablets Sales Volume by Application
  5. 5.2.1 Global Dihydroartemisinin Tablets Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Dihydroartemisinin Tablets Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Dihydroartemisinin Tablets Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Dihydroartemisinin Tablets Sales Value by Application
  9. 5.3.1 Global Dihydroartemisinin Tablets Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Dihydroartemisinin Tablets Sales Value by Application (2021-2032)
  11. 5.3.3 Global Dihydroartemisinin Tablets Sales Value Share by Application (2021-2032)
6 Dihydroartemisinin Tablets Regional Sales and Value Analysis
  1. 6.1 Global Dihydroartemisinin Tablets Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Dihydroartemisinin Tablets Sales by Region (2021-2032)
  3. 6.2.1 Global Dihydroartemisinin Tablets Sales by Region: 2021-2026
  4. 6.2.2 Global Dihydroartemisinin Tablets Sales by Region (2027-2032)
  5. 6.3 Global Dihydroartemisinin Tablets Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Dihydroartemisinin Tablets Sales Value by Region (2021-2032)
  7. 6.4.1 Global Dihydroartemisinin Tablets Sales Value by Region: 2021-2026
  8. 6.4.2 Global Dihydroartemisinin Tablets Sales Value by Region (2027-2032)
  9. 6.5 Global Dihydroartemisinin Tablets Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Dihydroartemisinin Tablets Sales Value (2021-2032)
  12. 6.6.2 North America Dihydroartemisinin Tablets Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Dihydroartemisinin Tablets Sales Value (2021-2032)
  15. 6.7.2 Europe Dihydroartemisinin Tablets Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Dihydroartemisinin Tablets Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Dihydroartemisinin Tablets Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Dihydroartemisinin Tablets Sales Value (2021-2032)
  21. 6.9.2 South America Dihydroartemisinin Tablets Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Dihydroartemisinin Tablets Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Dihydroartemisinin Tablets Sales Value Share by Country, 2025 VS 2032
7 Dihydroartemisinin Tablets Country-level Sales and Value Analysis
  1. 7.1 Global Dihydroartemisinin Tablets Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Dihydroartemisinin Tablets Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Dihydroartemisinin Tablets Sales by Country (2021-2032)
  4. 7.3.1 Global Dihydroartemisinin Tablets Sales by Country (2021-2026)
  5. 7.3.2 Global Dihydroartemisinin Tablets Sales by Country (2027-2032)
  6. 7.4 Global Dihydroartemisinin Tablets Sales Value by Country (2021-2032)
  7. 7.4.1 Global Dihydroartemisinin Tablets Sales Value by Country (2021-2026)
  8. 7.4.2 Global Dihydroartemisinin Tablets Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Dihydroartemisinin Tablets Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Dihydroartemisinin Tablets Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Dihydroartemisinin Tablets Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Dihydroartemisinin Tablets Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Dihydroartemisinin Tablets Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Dihydroartemisinin Tablets Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Dihydroartemisinin Tablets Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Dihydroartemisinin Tablets Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Dihydroartemisinin Tablets Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Dihydroartemisinin Tablets Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Dihydroartemisinin Tablets Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Dihydroartemisinin Tablets Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Dihydroartemisinin Tablets Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Dihydroartemisinin Tablets Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Dihydroartemisinin Tablets Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Dihydroartemisinin Tablets Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Dihydroartemisinin Tablets Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Dihydroartemisinin Tablets Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Dihydroartemisinin Tablets Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Dihydroartemisinin Tablets Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Dihydroartemisinin Tablets Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Dihydroartemisinin Tablets Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Dihydroartemisinin Tablets Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Dihydroartemisinin Tablets Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Dihydroartemisinin Tablets Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Dihydroartemisinin Tablets Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Dihydroartemisinin Tablets Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Dihydroartemisinin Tablets Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Dihydroartemisinin Tablets Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Dihydroartemisinin Tablets Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Dihydroartemisinin Tablets Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Dihydroartemisinin Tablets Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Dihydroartemisinin Tablets Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Dihydroartemisinin Tablets Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Dihydroartemisinin Tablets Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Dihydroartemisinin Tablets Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Dihydroartemisinin Tablets Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Dihydroartemisinin Tablets Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Dihydroartemisinin Tablets Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Dihydroartemisinin Tablets Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Dihydroartemisinin Tablets Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Dihydroartemisinin Tablets Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Dihydroartemisinin Tablets Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Dihydroartemisinin Tablets Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Dihydroartemisinin Tablets Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Dihydroartemisinin Tablets Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Dihydroartemisinin Tablets Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Dihydroartemisinin Tablets Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Dihydroartemisinin Tablets Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Dihydroartemisinin Tablets Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Dihydroartemisinin Tablets Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Dihydroartemisinin Tablets Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Dihydroartemisinin Tablets Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Dihydroartemisinin Tablets Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Dihydroartemisinin Tablets Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Dihydroartemisinin Tablets Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Dihydroartemisinin Tablets Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Dihydroartemisinin Tablets Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Dihydroartemisinin Tablets Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Dihydroartemisinin Tablets Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Dihydroartemisinin Tablets Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Dihydroartemisinin Tablets Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Dihydroartemisinin Tablets Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Dihydroartemisinin Tablets Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Dihydroartemisinin Tablets Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Dihydroartemisinin Tablets Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Dihydroartemisinin Tablets Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Dihydroartemisinin Tablets Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Dihydroartemisinin Tablets Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Dihydroartemisinin Tablets Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Dihydroartemisinin Tablets Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Dihydroartemisinin Tablets Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Dihydroartemisinin Tablets Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Dihydroartemisinin Tablets Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Dihydroartemisinin Tablets Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Dihydroartemisinin Tablets Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Dihydroartemisinin Tablets Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Dihydroartemisinin Tablets Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Dihydroartemisinin Tablets Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Dihydroartemisinin Tablets Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Dihydroartemisinin Tablets Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Dihydroartemisinin Tablets Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Dihydroartemisinin Tablets Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Dihydroartemisinin Tablets Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 KPC Pharmaceuticals
  2. 8.1.1 KPC Pharmaceuticals Company Information
  3. 8.1.2 KPC Pharmaceuticals Business Overview
  4. 8.1.3 KPC Pharmaceuticals Dihydroartemisinin Tablets Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 KPC Pharmaceuticals Dihydroartemisinin Tablets Product Portfolio
  6. 8.1.5 KPC Pharmaceuticals Recent Developments
  7. 8.2 Guilin Nantang Pharmaceutical
  8. 8.2.1 Guilin Nantang Pharmaceutical Company Information
  9. 8.2.2 Guilin Nantang Pharmaceutical Business Overview
  10. 8.2.3 Guilin Nantang Pharmaceutical Dihydroartemisinin Tablets Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Guilin Nantang Pharmaceutical Dihydroartemisinin Tablets Product Portfolio
  12. 8.2.5 Guilin Nantang Pharmaceutical Recent Developments
  13. 8.3 Schwitz Biotech
  14. 8.3.1 Schwitz Biotech Company Information
  15. 8.3.2 Schwitz Biotech Business Overview
  16. 8.3.3 Schwitz Biotech Dihydroartemisinin Tablets Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Schwitz Biotech Dihydroartemisinin Tablets Product Portfolio
  18. 8.3.5 Schwitz Biotech Recent Developments
  19. 8.4 Ipca Laboratories
  20. 8.4.1 Ipca Laboratories Company Information
  21. 8.4.2 Ipca Laboratories Business Overview
  22. 8.4.3 Ipca Laboratories Dihydroartemisinin Tablets Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Ipca Laboratories Dihydroartemisinin Tablets Product Portfolio
  24. 8.4.5 Ipca Laboratories Recent Developments
  25. 8.5 Centurion Healthcare
  26. 8.5.1 Centurion Healthcare Company Information
  27. 8.5.2 Centurion Healthcare Business Overview
  28. 8.5.3 Centurion Healthcare Dihydroartemisinin Tablets Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Centurion Healthcare Dihydroartemisinin Tablets Product Portfolio
  30. 8.5.5 Centurion Healthcare Recent Developments
  31. 8.6 AdvaCare Pharma
  32. 8.6.1 AdvaCare Pharma Company Information
  33. 8.6.2 AdvaCare Pharma Business Overview
  34. 8.6.3 AdvaCare Pharma Dihydroartemisinin Tablets Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 AdvaCare Pharma Dihydroartemisinin Tablets Product Portfolio
  36. 8.6.5 AdvaCare Pharma Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Dihydroartemisinin Tablets Value Chain Analysis
  2. 9.1.1 Dihydroartemisinin Tablets Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Dihydroartemisinin Tablets Sales Mode & Process
  6. 9.2 Dihydroartemisinin Tablets Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Dihydroartemisinin Tablets Distributors
  9. 9.2.3 Dihydroartemisinin Tablets Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst